GlobalHealth policy
International expert recommendations published on eye screening in incontinentia pigmenti
An international expert meeting prepared joint recommendations for eye problems in incontinentia pigmenti.
Skin diseases
An inherited disease seen mostly in girls. A rash and patches appear on the skin that change over the years. The teeth, hair, eyes and brain can also be affected.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Skin diseases” group.
The disease is caused by a change in the IKBKG gene. This gene protects cells against some harmful signals. In girls, some cells are healthy and some are affected. This is why skin changes appear in lines and swirls. The small blood vessels in the eyes and brain can also be affected.
Skin symptoms change in stages over the years.
The diagnosis is usually made from the typical skin findings. If needed, a genetic test of the IKBKG gene is done. The baby's eyes are examined often by an eye doctor in the first years. Because the disease can be mild, examining the mother is also recommended.
The skin findings usually clear up on their own. The skin is kept clean and infection is prevented. Blood vessel problems in the retina can be treated with freezing or laser. Seizures and nervous system problems are followed by a child neurologist. A children's dentist is needed for dental problems; implants can be done in childhood. Developmental support and special education may be needed. The doctor who follows the disease decides which treatment is suitable.
Incontinentia pigmenti is passed on through X-linked dominant inheritance. In about 65 percent of patients, the gene change is new. For an affected mother, the chance of passing on the gene in each pregnancy is 1 in 2. Male babies who get this gene are usually lost before birth. This is why most patients are girls. Genetic counselling and testing options during pregnancy can be discussed.
Source: MedlinePlus Genetics: Incontinentia pigmenti · GeneReviews: Incontinentia Pigmenti · NORD: Incontinentia Pigmenti
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
GlobalHealth policy
An international expert meeting prepared joint recommendations for eye problems in incontinentia pigmenti.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.
See all studies on ClinicalTrials.gov · Joining clinical trials
GlobalResearch and clinical trials
The trial included 222 adults with moderate-to-severe pemphigus.
TürkiyeResearch and clinical trials
In Türkiye, 12 centers jointly studied 69 patients from 52 families.
TürkiyeResearch and clinical trials
Eye doctors at Ankara University studied the eyes of 50 people with albinism.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:464 · ICD-11 LD27.00
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.